Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2611-2615

  Zhou, Qun ^a,c   Fukushima, Paula ^a   DeGraff, William ^a   Mitchell, James B ^a   Stetler Stevenson, Maryalice ^a   Ashkenazi, Avi ^b   Steeg, Patricia S ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GENENTECH INC   (United States)

^c GENZYME CORPORATION   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APO 2 LIGAND; CYCLIN D1; LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; CANCER PREVENTION; CONTROLLED STUDY; GAMMA RADIATION; HUMAN; HUMAN CELL; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE;

ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIVISION; CYCLIN D1; FEMALE; GAMMA RAYS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; PRECANCEROUS CONDITIONS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034657908     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med., 1: 1257-1260, 1995.
2. Simpson, J., Quan, D., O'Malley, F., Odom-Maryon, T., and Clarke, P. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am. J. Pathol., 151: 161-168, 1997.
3. Gillett, C., Lee, A., Millis, R., and Barnes, D. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J. Pathol., 184: 396-400, 1998.
4. Alle, K., Henshall, S., Field, A., and Sutherland, R. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res., 4: 847-854, 1998.
5. Asano, K., Sakamoto, H., Sasaki, H., and Ochiya, T. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem. Biophys. Res. Commun., 217: 1169-1176, 1995.
6. Zhou, P., Jiang, W., Weghorst, C. M., and Weinstein, I. B. Overexpression of cyclin D1 enhances gene amplification. Cancer Res., 56: 36-39, 1996.
7. Zwijsen, R., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 88: 405-415, 1997.
8. Kranenburg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
9. Martin, J., Balkenende, A., Verschoor, T., Lallemand, F., and Michalides, R. Cyclin D1 Overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res., 59: 1134-1140, 1999.
10. Han, E. K-H., Sgambato, A., Jiang, W., Zhang, Y-J., Santella, R., Doki, Y., Cacace, A., Schieren, I., and Weinstein, I. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10: 953-961, 1995.
11. Wang, T., Cardiff, R., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
12. Zhou, Q., Wulfkuhle, J., Ouatas, T., Fukushima, P., Stetler-Stevenson, M., Miller, F., and Steeg, P. Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent, but not anchorage-dependent growth is associated with increased cdk2 activity. Breast Cancer Res. Treat., 59: 27-39, 2000.
13. Pitti, R., Marsters, S., Ruppert, S., Donahue, C., Moore, A., and Ashkinazi, A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem., 271: 12687-12690, 1996.
14. Fisher, B., Digman, J., Wolmark, N., Mamounas, E., Constantino, J., Poller, J., Fisher, E., Wickerham, D., Deutsch, M., Margolese, R., Dimitrov, N., and Kavanah, M. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol., 16: 441-452, 1998.
15. Harris, J., and Morrow, M. Treatment of early stage breast cancer. In: J. Harros, M. E. Lippman, M. Morrow, and S. Hellman (eds.), Diseases of the Breast, pp. 487-547. Philadelphia: Lippincott-Raven, 1996.
16. Arteaga, C. Interference of the IGF system as a strategy to inhibit breast-cancer growth. Breast Cancer Res. Treat., 22: 101-106, 1992.
17. Manni, A., Wright, C., and Buck, H. Growth-factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res. Treat., 20: 43-52, 1991.
18. Wiley, S., Schooley, K., Smolak, P., Din, W., Huang, C-P., Nicholl, J., Sutherland, G., Smith, T., Rauch, C., Smith, C., and Goodwin, R. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3: 673-682, 1995.
19. Sheridan, J., Marsters, S., Pitti, R., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C., Baker, K., Wood, W., Goddard, A., Godowski, P., and Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (Washington DC), 277: 818-821, 1997.
20. Steeg, P., and Zhou, Q. Cyclins and breast cancer. Breast Cancer Res. Treat., 52: 17-28, 1998.